Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$766,076.00
Oct 1, 2012
Long chain omega-3 fatty acid supplementation and inflammation in metabolic syndrome: clinical and mechanistic studies
$151,667.00
Oct 1, 2012
Sensitivity to pain-related physical activity: underlying physiological mechanisms and clinical importance for chronic knee osteoarthritis
$275,000.00
Sep 1, 2012
Development and validation of clinical prediction rules of quality of life in head and neck cancer
$618,785.00
Oct 1, 2012
Modulation of ischemia-induced postnatal neovascularization by clinical phenotype and oxidative stress: Role of micro RNAs
$390,342.00
Oct 1, 2012
The Pharmacogenetics of Bevacizumab: A Companion Correlative Study of the Ovarian Cancer Clinical Trial, ICON7
$100,000.00
Jul 1, 2016
Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation
$1,280,540.00
Jul 1, 2016
Transgender youth in clinical care: A pan-Canadian cohort study of medical, social and family outcomes
$240,818.00
Jul 1, 2016
Endoscopic Polypectomy performed In Clinic for chronic rhinosinusitis with polyps: The EPIC multicenter randomised controlled trial
$348,074.00
Apr 1, 2017
Atrial Fibrillation in the Emergency Room (The AFTER Study): Prospective validation of the clinical decision instruments
$3,186,224.00
Apr 1, 2017
Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation